Entacapone significantly decreases elevated plasma homocysteine levels in levodopa-treated Parkinson's disease patients

被引：0
|
作者：
Nissinen, H
Ellmen, J
Vahteristo, M
机构：
来源：
MOVEMENT DISORDERS | 2005年 / 20卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P315
引用
收藏
页码：S94 / S94
页数：1
相关论文
共 50 条
  • [1] Reduced plasma homocysteine levels in levodopa/entacapone treated Parkinson patients
    Valkovic, P
    Benetin, J
    Blazicek, P
    Valkovicová, L
    Gmitterová, K
    Kukumberg, P
    [J]. PARKINSONISM & RELATED DISORDERS, 2005, 11 (04) : 253 - 256
  • [2] Elevated homocysteine levels in levodopa-treated idiopathic Parkinson's disease: a meta-analysis
    Hu, X. -W.
    Qin, S. -M.
    Li, D.
    Hu, L. -F.
    Liu, C. -F.
    [J]. ACTA NEUROLOGICA SCANDINAVICA, 2013, 128 (02): : 73 - 82
  • [3] Effect of levodopa and entacapone treatment on plasma homocysteine levels in Parkinson's disease patients
    Nevrly, M.
    Kanovsky, P.
    Vranova, H.
    Langova, K.
    Hlustik, P.
    [J]. PARKINSONISM & RELATED DISORDERS, 2009, 15 (06) : 477 - 478
  • [4] Entacapone improves motor fluctuations in levodopa-treated Parkinson's disease patients
    Kieburtz, K
    Shoulson, I
    Fahn, S
    McDermott, M
    Koller, W
    LeWitt, P
    Nutt, J
    Kurth, M
    Brewer, M
    Lew, M
    Welsh, M
    Waters, C
    Bennett, J
    RostRuffner, E
    Feigin, A
    Gardiner, I
    Kurlan, R
    Hammerstad, J
    Stone, C
    Jankovic, J
    Beach, J
    Tetrud, J
    Kelker, K
    Standaert, DG
    Growdon, JH
    Tennis, M
    Graefe, K
    Mark, MH
    Kelly, SJ
    Pahwa, R
    McGuire, D
    Hubble, J
    Factor, SA
    Brown, DL
    Tuite, P
    Sime, E
    Lang, DL
    Greene, P
    Winfield, H
    Paulson, G
    Zoog, K
    Weeks, C
    Shults, C
    Fontaine, D
    Juncos, JL
    Wood, C
    Shannon, K
    Jaglin, JA
    Tornabene, J
    Lannon, MC
    [J]. ANNALS OF NEUROLOGY, 1997, 42 (05) : 747 - 755
  • [5] Hyperhomocysteinemia in levodopa-treated Parkinson patients prevented by entacapone
    Benetin, J
    Valkovic, P
    Blazicek, P
    Valkovicova, L
    Gmitterova, K
    Kukumberg, P
    [J]. MOVEMENT DISORDERS, 2004, 19 : S183 - S183
  • [6] Effect of COMT inhibitor entacapone on plasma homocysteine levels in levodopa-treated rats.
    Nissinen, E
    Haapaniemi, H
    Rauhala, P
    [J]. MOVEMENT DISORDERS, 2004, 19 (09) : 1129 - 1129
  • [7] Effect of vitamin B12, folate, and entacapone on homocysteine levels in levodopa-treated Parkinson's disease patients: A randomized controlled study
    Anamnart, Chumpol
    Kitjarak, Ram
    [J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 2021, 429 : 319 - 319
  • [8] Effects of vitamin B12, folate, and entacapone on homocysteine levels in levodopa-treated Parkinson's disease patients: A randomized controlled study
    Anamnart, Chumpol
    Kitjarak, Ram
    [J]. JOURNAL OF CLINICAL NEUROSCIENCE, 2021, 88 : 226 - 231
  • [9] Methylenetetrahydrofolate reductase polymorphisms and plasma homocysteine in levodopa-treated and non-treated Parkinson's disease patients
    Yuan, Rey-Yue
    Sheu, Jau-Jiuan
    Yu, Jia-Ming
    Hu, Chaur-Jong
    Tseng, Ing-Jy
    Ho, Chun-Sum
    Yeh, Ching-Ying
    Hung, Ya-Lin
    Chiang, Tsuey-Ru
    [J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 2009, 287 (1-2) : 64 - 68
  • [10] Entacapone decreases axial symptoms and tremor in levodopa-treated Parkinson's disease patients experiencing wearing-off symptoms
    Brooks, DJ
    Kuoppamäki, M
    Vahteristo, M
    [J]. MOVEMENT DISORDERS, 2005, 20 : S120 - S120
12345